Evidence map›Paper›PMID 35890329›Full record

ArticlePharmaceutics2022

Advanced Online Monitoring of In Vitro Human 3D Full-Thickness Skin Equivalents.

Roland Schaller-Ammann, Sebastian Kreß, Jürgen Feiel, Gerd Schwagerle, Joachim Priedl, Thomas Birngruber, Cornelia Kasper, Dominik Egger

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Roland Schaller-AmmannHealth-Institute for Biomedicine and Health Sciences, Joanneum Research Forschungsgesellschaft mbH, Neue Stiftingtalstrasse 2, 8010 Graz, Austria.
Sebastian KreßInstitute of Cell and Tissue Culture Technologies, Department of Biotechnology, University of Natural, Resources and Life Sciences, Vienna, Muthgasse 18, 1190 Vienna, Austria.
Jürgen FeielHealth-Institute for Biomedicine and Health Sciences, Joanneum Research Forschungsgesellschaft mbH, Neue Stiftingtalstrasse 2, 8010 Graz, Austria.
Gerd SchwagerleHealth-Institute for Biomedicine and Health Sciences, Joanneum Research Forschungsgesellschaft mbH, Neue Stiftingtalstrasse 2, 8010 Graz, Austria.ORCID 0000-0001-6567-1479
Joachim PriedlHealth-Institute for Biomedicine and Health Sciences, Joanneum Research Forschungsgesellschaft mbH, Neue Stiftingtalstrasse 2, 8010 Graz, Austria.
Thomas BirngruberHealth-Institute for Biomedicine and Health Sciences, Joanneum Research Forschungsgesellschaft mbH, Neue Stiftingtalstrasse 2, 8010 Graz, Austria.ORCID 0000-0001-8827-4660
Cornelia KasperInstitute of Cell and Tissue Culture Technologies, Department of Biotechnology, University of Natural, Resources and Life Sciences, Vienna, Muthgasse 18, 1190 Vienna, Austria.ORCID 0000-0003-2607-4326
Dominik EggerInstitute of Cell and Tissue Culture Technologies, Department of Biotechnology, University of Natural, Resources and Life Sciences, Vienna, Muthgasse 18, 1190 Vienna, Austria.ORCID 0000-0002-9925-3344
Joanneum Research · ATBOKU University · AT

Funding

Austrian Federal Ministry of Education, Science and Research - BMWFW 859279Austrian Research Promotion Agency 859279
6 · The paper itself

Abstract

Skin equivalents and skin explants are widely used for dermal penetration studies in the pharmacological development of drugs. Environmental parameters, such as the incubation and culture conditions affect cellular responses and thus the relevance of the experimental outcome. However, available systems such as the Franz diffusion chamber, only measure in the receiving culture medium, rather than assessing the actual conditions for cells in the tissue. We developed a sampling design that combines open flow microperfusion (OFM) sampling technology for continuous concentration measurements directly in the tissue with microfluidic biosensors for online monitoring of culture parameters. We tested our design with real-time measurements of oxygen, glucose, lactate, and pH in full-thickness skin equivalent and skin explants. Furthermore, we compared dermal penetration for acyclovir, lidocaine, and diclofenac in skin equivalents and skin explants. We observed differences in oxygen, glucose, and drug concentrations in skin equivalents compared to the respective culture medium and to skin explants.

Indexed as

full-thickness skin equivalentglucoselactateopen flow microperfusionoxygenpenetration testspHpharmacokineticssensorsskin explants

Identifiers

PMID35890329
PMCPMC9315769
OpenAlexW4285008714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.